American Century Companies has boosted its stake in Biohaven (BHVN) by 9.5% during Q4, ETF Daily News reports, citing a recent SEC filing. The firm owned 558,761 shares of Biohaven after purchasing an ...

American Century Companies Inc. increased its position in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 9.5% during ...

Xponance Inc. lifted its position in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 25.9% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 6,148 shares of ...

Investors’ deep pessimism is actually bullish, and less regulatory constraint could fuel new drug approvals and M&A.

Highlights,Institutional investments in Biohaven Ltd. have shown recent increases.,The company focuses on developing therapies in neuroscience, immunology, and oncology.,Research pipeline includes ...

NEW YORK, NY / ACCESS Newswire / March 16, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of ...

On Monday, Piper Sandler reiterated its Overweight rating and $76.00 price target on Biohaven Pharmaceutical (TADAWUL:2070) ...

(Reuters) -AbbVie Inc said on Tuesday the U.S. health regulator approved its once-daily oral medicine for preventive treatment of ...

In trading on Thursday, shares of Biohaven Ltd (Symbol: BHVN) entered into oversold territory, hitting an RSI reading of 29.7, after changing hands as low as $28.47 per share. By comparison ...

Roche (OTCQX:RHHBY) is looking to boost its presence in the booming weight-loss market through an exclusive collaboration and licensing deal with Danish biotech Zealand Pharma (OTCPK:ZLDPF). Under the ...

In this article, we are going to take a look at where Biohaven Ltd. (NYSE:BHVN) stands against other stocks with heavy insider buying in 2025. Insider trading is often seen as an important ...